Figure S4 shows the body weights and organ weights between the groups. There was no significant difference observed between the groups. In the visfatin group, the size and weight of the tumor after sacrifice were significantly higher than those in the control group, and the combined intervention of CA or FK866 showed weights significantly lower than that of the visfatin group (p < 0.05) (Figure 6B). The gene discussed is NAMPT; the disease is neoplasm.